Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations
Roland B. Walter, Yishai Ofran, Agnieszka Wierzbowska, Farhad Ravandi, Christopher S. Hourigan, Lok Lam Ngai, Adriano Venditti, Francesco Buccisano, Gert J. Ossenkoppele, Gail J. Roboz
Topics & Concepts
MedicineMinimal residual diseaseBiomarkerOncologyMyeloid leukemiaClinical trialInternal medicineDiseaseLeukemiaBiochemistryChemistryAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsChronic Myeloid Leukemia Treatments